HMGB1 and myeloproliferative disorder: As shown in Supplementary figure 3, plasma HMGB1 levels were measured in 83 MPN patients, including 37 ET, 23 PV, and 23 MF (comprising five post-ETMF, six post-PV-MF, and 12 PMF), along with 29 controls.